RTTNews BiotechDoubao · 实盘不做把握 8/10不做原因:已被定价
北京时间·🕒 发布 13:20:30(美东 01:20)·⟳ 抓取 13:25:24 +4m54s·⚡ 决策 10-22 13:27:34 +2m10s·5.4 天前
EQT牵头财团以每股46.50欧元全现金收购凯杰（QIAGEN），估值约108亿欧元，股价已贴满要约价
同一收购协议已于10月21日由公司与EQT官方宣布，本条RTTNews仅为延迟转载、无新增事实；QGEN隔夜50.14美元已等于/略高于46.50欧元要约按当前汇率折算的约50.2–50.7美元，并购套利价差基本为零，资金却要锁定至2027年中并承担接受率、EGM、多国监管、汇率及2020年赛默飞要约破裂史风险；做空则有硬要约价支撑及第三方提价尾部，多空两边均无正期望。
📄 原文RTTNews Biotech↗ 原文
QIAGEN Agrees To EQT Takeover Offer For All Outstanding Shares At €46.50/share
Qiagen N.V. (QGEN) on Wednesday said it has agreed to an all-cash takeover offer by EQT Private Equity at €46.50 per sh…
不做 QIAGEN N.V.（凯杰）（QGEN.US）
已充分price-in且无套利价差：隔夜50.14美元已贴满46.50欧元要约折美元价（约50.2–50.7美元），上行不足1%，资金却要锁定至2027年中并承担接受率/EGM/多国监管/汇率及2020年要约破裂史风险；做空则有硬要约价支撑及KKR等第三方提价尾部，多空均无正期望。本条RTTNews为10月21日官方协议的重复转载，无新增事实。
不做 EQT AB（EQT.SE）
收购主体为EQT XI基金，交易对上市资管平台仅间接、长期的管理费增量，相对其AUM不具短线弹性，无可交易方向。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
EQT以46.50欧元/股、约108亿欧元全现金收购QIAGEN，董事会一致推荐且融资已落实，但股价（隔夜50.14美元）已完全贴满要约折美元价值，收购预期自7月起、签约前Bloomberg又已明牌，套利空间消失，剩余8–9个月只有破发与汇率风险，多空均不做。
🔎 新鲜度:最早出现 2026-10-21 · 扩散 high · price-in 风险 high ↗
关键理由
- 要约已充分定价：46.50欧元按公告汇率折约50.2–50.7美元，QGEN隔夜50.14美元已无套利价差，上行空间不足1%
- 风险收益不对称：资金需锁定至2027年中，承担接受率、EGM投票、多国监管审批、欧元汇率及2020年要约破裂史的下行风险，却无收益补偿
主要风险
- 若出现KKR等第三方竞购加价，做空将被逼空（故不做空）；若交易失败，股价可能回落至44–46美元（故不做多）
- 50%+1接受门槛、EGM后置措施批准及外资/反垄断审查存在不通过或延期风险
反向证据
- 做多前查反向 · 来源 search_processed_events · 日期 2026-10-22 · 影响 weakens
2020年赛默飞对QIAGEN的要约因未达最低接受门槛而失败；本交易仍需50%+1接受、EGM及多国审批，2027年中才交割，破发风险真实存在，削弱做多
检索:Qiagen EQT deal failure antitrust shareholder acceptance 2020 Thermo Fisher - 做空前查反向 · 来源 search_processed_events · 日期 2026-10-22 · 影响 weakens
此前报道存在多方PE竞购兴趣，不排除第三方提价尾部，且46.50欧元硬要约价对股价构成支撑，做空无安全边际
检索:KKR competing bid Qiagen EQT auction
先例如何影响了这次决策
对本次决策的影响:确认多空均不做：做多无价差、做空有硬支撑与提价尾部
方向:本案核心不是事件方向而是并购套利价差是否存在；同臂72小时内已基于官方公告对同一交易作出多次不做决策，且QGEN现价已贴满要约价，无需再用外部先例校准
涨幅量级:上行空间已被要约价硬性封顶（46.50欧元折约50.2–50.7美元，现价50.14美元），不存在用先例涨幅设定tp的空间
形态:QIAGEN自身2020年赛默飞要约因未达接受门槛而失败，构成本交易的破发尾部参考；且收购预期明牌后两日大涨+盘后冲高回落符合签约兑现特征
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 2,147 ms
{"result": "search_processed_events:agent query=`eqt 凯杰 收购 私有化 108亿欧元 | qiagen eqt takeover offer €46.50 per share | qiagen qgen crown nl bidco acquisition all-cash`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 72.0/72 小时、28342 条本臂决策(完整)，返回 6 条候选。\n• 10-21 21:55 UTC(北京 10-22 05:55) [bm25:74%] 不做 EQT.ST,QGEN.US (ir_page - stock_quote 成功 stock_tools HTTP · 473 ms
{
原文全文
展开原文 · 1,787 字
Qiagen N.V. (QGEN) on Wednesday said it has agreed to an all-cash takeover offer by EQT Private Equity at €46.50 per share, valuing the company at approximately €10.8 billion, or $12.1 billion, including $1.1 billion of net debt.
The offer represents a 40.3% premium to QIAGEN's July 8 closing price, before reports of private-equity takeover interest, and a 46.9% premium to its three-month volume-weighted average price through that date.
Crown NL Bidco, indirectly controlled by EQT XI, will make the offer, with affiliates of the Abu Dhabi Investment Authority and Canada Pension Plan Investment Board (CPP Investments) participating as co-investors.
QIAGEN's supervisory and managing boards unanimously approved the agreement and agreed to recommend that shareholders accept the offer.
Closing is expected in mid-2027, subject to acceptance by holders of 50% of outstanding shares plus one share, required shareholder resolutions, regulatory clearances and other conditions.
EQT has secured committed equity and debt financing. The transaction has no financing condition.
QIAGEN will remain independently operated under its current management until closing. Its Frankfurt and New York listings will be terminated as part of the planned post-closing measures.
QGEN closed at $50, up 2.25%.
In the overnight trading on Thursday, shares rose 0.28% to $50.14.
For comments and feedback contact: editorial@rttnews.com
Business News
October 16, 2026 16:06 ET Monthly consumer price inflation data and retail sales figures were the main news from the U.S. economy this week. In Europe, monthly GDP figures from the U.K. gained attention. External trade data from China was in focus in Asia. Elsewhere, the International Monetary Fund released its latest projections for the global economy.
The offer represents a 40.3% premium to QIAGEN's July 8 closing price, before reports of private-equity takeover interest, and a 46.9% premium to its three-month volume-weighted average price through that date.
Crown NL Bidco, indirectly controlled by EQT XI, will make the offer, with affiliates of the Abu Dhabi Investment Authority and Canada Pension Plan Investment Board (CPP Investments) participating as co-investors.
QIAGEN's supervisory and managing boards unanimously approved the agreement and agreed to recommend that shareholders accept the offer.
Closing is expected in mid-2027, subject to acceptance by holders of 50% of outstanding shares plus one share, required shareholder resolutions, regulatory clearances and other conditions.
EQT has secured committed equity and debt financing. The transaction has no financing condition.
QIAGEN will remain independently operated under its current management until closing. Its Frankfurt and New York listings will be terminated as part of the planned post-closing measures.
QGEN closed at $50, up 2.25%.
In the overnight trading on Thursday, shares rose 0.28% to $50.14.
For comments and feedback contact: editorial@rttnews.com
Business News
October 16, 2026 16:06 ET Monthly consumer price inflation data and retail sales figures were the main news from the U.S. economy this week. In Europe, monthly GDP figures from the U.K. gained attention. External trade data from China was in focus in Asia. Elsewhere, the International Monetary Fund released its latest projections for the global economy.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
da496f2d8a· 2026-10-22 13:27 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前